Manufacturers of hormone replacement drugs should change their labels to tell women they can raise the risk of dementia and abnormal mammograms, the U.S. government said on Tuesday.
Manufacturers of hormone replacement drugs should change their labels to tell women they can raise the risk of dementia and abnormal mammograms, the U.S. government said on Tuesday.